Open Access

Erratum to: Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats

  • Pil-Sung Yang1,
  • Dae-Hoon Kim1,
  • Yong Joon Lee2,
  • Sang-Eun Lee1,
  • Won Jun Kang3,
  • Hyuk-Jae Chang1, 4Email author and
  • Jeon-Soo Shin2, 4
Respiratory Research201617:142

https://doi.org/10.1186/s12931-016-0458-9

Received: 19 October 2016

Accepted: 28 October 2016

Published: 4 November 2016

The original article was published in Respiratory Research 2014 15:148

Erratum

In the original article [1], the following information was omitted from the funding section:

“This study was supported by a faculty research grant of Yonsei University College of Medicine for 2009 (6-2009-0101).”

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System
(2)
Departments of Microbiology, Yonsei University College of Medicine
(3)
Departments of Nuclear Medicine, Yonsei University College of Medicine
(4)
Severance Biomedical Science Institute, Yonsei University Health System

Reference

  1. Yang, et al. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Respir Res. 2016;15(1):148.View ArticleGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement